{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:16:44Z","timestamp":1794572204594,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Hai Yan Fund of The Third Affiliated Hospital of Harbin Medical University, Harbin, China","award":["JJZD2023-01"],"award-info":[{"award-number":["JJZD2023-01"]}]},{"name":"the guidance of Xiamen Health Care","award":["3502Z2014ZD1142"],"award-info":[{"award-number":["3502Z2014ZD1142"]}]},{"name":"the Young Investigator Research Program of Xiang\u2019an Hospital of Xiamen University","award":["XM01320001"],"award-info":[{"award-number":["XM01320001"]}]},{"name":"the Outstanding Youth Foundation of Heilongjiang Province of China","award":["YQ2023H002"],"award-info":[{"award-number":["YQ2023H002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06205-y","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:22:36Z","timestamp":1739791356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["RBM15 recruits myeloid-derived suppressor cells via the m6A-IGF2BP3\/CBR3-AS1\/miR-409-3p\/CXCL1 axis, facilitating radioresistance in non-small-cell lung cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Songliu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishuang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6868-2752","authenticated-orcid":false,"given":"Shilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"1","key":"6205_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"6205_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","volume":"21","author":"DS Ettinger","year":"2023","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN guidelines(R) insights: non-small cell lung cancer, version 2.2023. J Natl Compr Canc Netw. 2023;21(4):340\u201350. https:\/\/doi.org\/10.6004\/jnccn.2023.0020.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"6205_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.semradonc.2014.11.001","volume":"25","author":"SK Vinod","year":"2015","unstructured":"Vinod SK. International patterns of radiotherapy practice for non-small cell lung cancer. Semin Radiat Oncol. 2015;25(2):143\u201350. https:\/\/doi.org\/10.1016\/j.semradonc.2014.11.001.","journal-title":"Semin Radiat Oncol"},{"key":"6205_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.11.009","volume":"526","author":"S Liu","year":"2022","unstructured":"Liu S, Zhan N, Gao C, Xu P, Wang H, Wang S, et al. Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1 \/miR-409\u20133p\/SOD1 axis. Cancer Lett. 2022;526:1\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.009.","journal-title":"Cancer Lett"},{"issue":"1","key":"6205_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12935-020-01685-y","volume":"21","author":"M Hou","year":"2021","unstructured":"Hou M, Wu N, Yao L. LncRNA CBR3-AS1 potentiates Wnt\/beta-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion. Cancer Cell Int. 2021;21(1):36. https:\/\/doi.org\/10.1186\/s12935-020-01685-y.","journal-title":"Cancer Cell Int"},{"key":"6205_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.omto.2022.03.001","volume":"25","author":"W Yao","year":"2022","unstructured":"Yao W, Hou J, Liu G, Wu F, Yan Q, Guo L, et al. LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140\u20135p\/DDX54-NUCKS1-mTOR signaling pathway. Mol Ther Oncolytics. 2022;25:189\u2013200. https:\/\/doi.org\/10.1016\/j.omto.2022.03.001.","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"6205_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13046-021-01844-7","volume":"40","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang Y, Jiang L, Song X, Zheng A, Gao H, et al. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1\/MEK4-mediated MAPK signal pathway. J Exp Clin Cancer Res. 2021;40(1):41. https:\/\/doi.org\/10.1186\/s13046-021-01844-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6409","key":"6205_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361(6409):1346\u20139. https:\/\/doi.org\/10.1126\/science.aau1646.","journal-title":"Science"},{"issue":"5","key":"6205_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm3785","volume":"15","author":"KD Meyer","year":"2014","unstructured":"Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15(5):313\u201326. https:\/\/doi.org\/10.1038\/nrm3785.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"6205_CR10","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187\u2013200. https:\/\/doi.org\/10.1016\/j.cell.2017.05.045.","journal-title":"Cell"},{"issue":"1","key":"6205_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","volume":"22","author":"H Fang","year":"2023","unstructured":"Fang H, Sun Q, Zhou J, Zhang H, Song Q, Zhang H, et al. m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer. 2023;22(1):99. https:\/\/doi.org\/10.1186\/s12943-023-01791-1.","journal-title":"Mol Cancer"},{"issue":"7","key":"6205_CR12","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","volume":"41","author":"L Wang","year":"2023","unstructured":"Wang L, Dou X, Chen S, Yu X, Huang X, Zhang L, et al. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell. 2023;41(7):1294\u2013308. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.019.","journal-title":"Cancer Cell"},{"issue":"1","key":"6205_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-021-01871-4","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X, Tian L, Li Y, Wang J, Yan B, Yang L, et al. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res. 2021;40(1):80. https:\/\/doi.org\/10.1186\/s13046-021-01871-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6205_CR14","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s41467-017-01566-5","volume":"8","author":"H Liang","year":"2017","unstructured":"Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E, et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun. 2017;8(1):1736. https:\/\/doi.org\/10.1038\/s41467-017-01566-5.","journal-title":"Nat Commun"},{"key":"6205_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215598","author":"X Zhou","year":"2022","unstructured":"Zhou X, Fang D, Liu H, Ou X, Zhang C, Zhao Z, et al. PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer. Cancer Lett. 2022. https:\/\/doi.org\/10.1016\/j.canlet.2022.215598.","journal-title":"Cancer Lett"},{"key":"6205_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00213","author":"S Liu","year":"2020","unstructured":"Liu S, Li B, Xu J, Hu S, Zhan N, Wang H, et al. SOD1 promotes cell proliferation and metastasis in non-small cell lung cancer via an miR-409\u20133p\/SOD1\/SETDB1 epigenetic regulatory feedforward loop. Front Cell Dev Biol. 2020. https:\/\/doi.org\/10.3389\/fcell.2020.00213.","journal-title":"Front Cell Dev Biol"},{"key":"6205_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105557","author":"JC Fleet","year":"2020","unstructured":"Fleet JC, Burcham GN, Calvert RD, Elzey BD, Ratliff TL. 1alpha, 25 Dihydroxyvitamin D (1,25(OH)(2)D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC). J Steroid Biochem Mol Biol. 2020. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105557.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"6205_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: Roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270\u201388. https:\/\/doi.org\/10.1016\/j.ccell.2020.02.004.","journal-title":"Cancer Cell"},{"issue":"1","key":"6205_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, et al. Molecular characterization and clinical relevance of m(6)A regulators across 33 cancer types. Mol Cancer. 2019;18(1):137. https:\/\/doi.org\/10.1186\/s12943-019-1066-3.","journal-title":"Mol Cancer"},{"issue":"6","key":"6205_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tcb.2019.02.008","volume":"29","author":"J Liu","year":"2019","unstructured":"Liu J, Harada BT, He C. Regulation of gene expression by N(6)-methyladenosine in cancer. Trends Cell Biol. 2019;29(6):487\u201399. https:\/\/doi.org\/10.1016\/j.tcb.2019.02.008.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"6205_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","volume":"20","author":"P Nombela","year":"2021","unstructured":"Nombela P, Miguel-Lopez B, Blanco S. The role of m(6)A, m(5)C and Psi RNA modifications in cancer: novel therapeutic opportunities. Mol Cancer. 2021;20(1):18. https:\/\/doi.org\/10.1186\/s12943-020-01263-w.","journal-title":"Mol Cancer"},{"issue":"45","key":"6205_CR22","doi-asserted-by":"publisher","first-page":"19056","DOI":"10.1039\/d1nr05385j","volume":"13","author":"S Bhattarai","year":"2021","unstructured":"Bhattarai S, Mackeyev Y, Venkatesulu BP, Krishnan S, Singh PK. CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer. Nanoscale. 2021;13(45):19056\u201365. https:\/\/doi.org\/10.1039\/d1nr05385j.","journal-title":"Nanoscale"},{"key":"6205_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","volume":"117","author":"BH Li","year":"2020","unstructured":"Li BH, Garstka MA, Li ZF. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor. Mol Immunol. 2020;117:201\u201315. https:\/\/doi.org\/10.1016\/j.molimm.2019.11.014.","journal-title":"Mol Immunol"},{"issue":"12","key":"6205_CR24","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1126\/sciadv.abh4050","volume":"8","author":"T Walle","year":"2022","unstructured":"Walle T, Kraske JA, Liao B, Lenoir B, Timke C, et al. Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8. Sci Adv. 2022;8(12):4050. https:\/\/doi.org\/10.1126\/sciadv.abh4050.","journal-title":"Sci Adv"},{"issue":"12","key":"6205_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374. https:\/\/doi.org\/10.1038\/nrg3074.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"6205_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19(1):88. https:\/\/doi.org\/10.1186\/s12943-020-01204-7.","journal-title":"Mol Cancer"},{"issue":"11","key":"6205_CR27","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/tox.23883","volume":"38","author":"J Chen","year":"2023","unstructured":"Chen J. Regulatory mechanism of RNA binding motif protein 15-mediated N(6) methyladenosine modification in proliferation, invasion, and migration of colorectal cancer cells. Environ Toxicol. 2023;38(11):2545\u201359. https:\/\/doi.org\/10.1002\/tox.23883.","journal-title":"Environ Toxicol"},{"issue":"9","key":"6205_CR28","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/tox.23852","volume":"38","author":"Y Song","year":"2023","unstructured":"Song Y, Wu Q. RBM15 m(6) A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT\/mTOR signaling. Environ Toxicol. 2023;38(9):2155\u201364. https:\/\/doi.org\/10.1002\/tox.23852.","journal-title":"Environ Toxicol"},{"issue":"3","key":"6205_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/0008-5472.CAN-23-0609","volume":"84","author":"X Guo","year":"2024","unstructured":"Guo X, Qiu W, Wang C, Qi Y, Li B, Wang S, et al. Neuronal activity promotes glioma progression by inducing proneural-to-mesenchymal transition in glioma stem cells. Cancer Res. 2024;84(3):372\u201387. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0609.","journal-title":"Cancer Res"},{"issue":"1","key":"6205_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","volume":"11","author":"TY Zhu","year":"2023","unstructured":"Zhu TY, Hong LL, Ling ZQ. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res. 2023;11(1):62. https:\/\/doi.org\/10.1186\/s40364-023-00499-0.","journal-title":"Biomark Res"},{"key":"6205_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154299","author":"Y Cui","year":"2022","unstructured":"Cui Y, Wu Y, Wang C, Wang Z, Li Y, Jiang Z, et al. Isoliquiritigenin inhibits non-small cell lung cancer progression via m(6)A\/IGF2BP3-dependent TWIST1 mRNA stabilization. Phytomedicine. 2022. https:\/\/doi.org\/10.1016\/j.phymed.2022.154299.","journal-title":"Phytomedicine"},{"issue":"1","key":"6205_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-022-02573-1","volume":"42","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chen Q, He Y, Shi Q, Yin C, Xie Y, et al. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res. 2023;42(1):19. https:\/\/doi.org\/10.1186\/s13046-022-02573-1.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:22:48Z","timestamp":1739791368000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6205"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06205-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human tumor tissue samples were collected in accordance with national and in-stitutional ethical guidelines. The protocol employed in this study was approved by the Medical Ethics Committee (KY2022-57). All patients have signed informed consent forms. All animal studies (including the mice euthanasia procedure) complied with the regulations and guidelines of Harbin Medical University institutional animal care (JJZD 2023-01) and conducted according to The American Association for Laboratory Animal Science and the Institutional Animal Care and Use Committee guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}